NCT05737225

Brief Summary

In this study, the effects of regional anesthesia method applied in patients who will undergo percutaneous transluminal angioplasty for lower extremity revascularization will be investigated comparatively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 24, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

February 3, 2023

Completed
18 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2023

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

December 20, 2023

Status Verified

December 1, 2023

Enrollment Period

7 months

First QC Date

February 3, 2023

Last Update Submit

December 19, 2023

Conditions

Keywords

percutaneous transluminal angioplastytissue oxygenation

Outcome Measures

Primary Outcomes (1)

  • Tissue Oxygenation

    Tissue oxygenation will be measured from both lower extremities by Near Infrared Spectroscopy for 30 min after popliteal sciatic nerve block and during procedure.

    During procedure

Secondary Outcomes (3)

  • Body Temperature of Lower Extremities

    During procedure

  • Patient Satisfaction Score

    15 minutes after procedure

  • Surgeon Satisfaction Score

    15 minutes after procedure

Study Arms (2)

Popliteal sciatic nerve block group

regional anesthesia applied patients who will undergo percutaneous transluminal angioplasty (PTA) procedure

Device: Near Infrared Spectroscopy (NIRS)

Control group

patients who will undergo percutaneous transluminal angioplasty (PTA) procedure

Device: Near Infrared Spectroscopy (NIRS)

Interventions

We will place Near Infrared Spectroscopy (NIRS) electrode on the foot to evaluate regional tissue oxygen saturation in both lower extremities before the performing regional anesthesia (popliteal sciatic nerve block) and then during the procedure.

Control groupPopliteal sciatic nerve block group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ASA I-III patients over the age of 18 who have been decided to perform elective PTA as a treatment method for peripheral arterial disease will be included in the study.

You may qualify if:

  • Age: \> 18 years
  • Peripheral artery occlusive disease
  • Eligibility for PTA

You may not qualify if:

  • Patients' refusal
  • Under the age of 18
  • Language problems (not knowing turkish)
  • Psychological or mental disorders.
  • Disturbance of Conscious level.
  • Uncooperative patients
  • Those who are allergic to anesthetic drugs to be used
  • Those with contraindications for the application of peripheral nerve block (coagulopathy, skin infection at the block site)
  • need for endotracheal intubation or general anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University

Ankara, 06490, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Peripheral Arterial Occlusive Disease 1

Interventions

Spectroscopy, Near-Infrared

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

February 3, 2023

First Posted

February 21, 2023

Study Start

September 24, 2022

Primary Completion

April 17, 2023

Study Completion

May 1, 2023

Last Updated

December 20, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations